EntroGen, Inc., a leading provider of molecular diagnostic solutions in oncology, today announced the launch of its Microsatellite Instability (MSI) Detection Kit (RUO) — a modern PCR-based assay designed to deliver fast, reliable MSI detection with a streamlined workflow that is compatible with most qPCR instruments.
Microsatellite instability (MSI) is a defining feature of a subset of colorectal cancers. EntroGen’s MSI Detection Kit (RUO) applies a high-resolution melting (HRM) workflow to detect instability efficiently and reliably—bringing seamless MSI analysis to qPCR-equipped laboratories. In addition, EntroGen provides complimentary software for efficient data analysis, allowing users to easily visualize and interpret HRM results.
The assay incorporates well-established targets for MSI detection— BAT-25, BAT-26, NR-21, NR-27, and MONO-27 — selected for their strong association with microsatellite instability in colorectal cancer, ensuring sensitive and reproducible detection results.
“Many MSI testing methods on the market have their own unique challenges,” said Matthew Minkovsky, CEO of EntroGen. “With our kit, we’ve simplified the testing process by removing unnecessary technical barriers and offering a solution that’s both high-performing and easy to adopt on leading qPCR platforms.”
The kit is now available directly from EntroGen and through its network of authorized distributors.